Literature DB >> 22451099

Cognitive domains that predict time to diagnosis in prodromal Huntington disease.

Deborah Lynn Harrington1, Megan M Smith, Ying Zhang, Noelle E Carlozzi, Jane S Paulsen.   

Abstract

BACKGROUND: Prodromal Huntington's disease (prHD) is associated with a myriad of cognitive changes but the domains that best predict time to clinical diagnosis have not been studied. This is a notable gap because some domains may be more sensitive to cognitive decline, which would inform clinical trials.
OBJECTIVES: The present study sought to characterise cognitive domains underlying a large test battery and for the first time, evaluate their ability to predict time to diagnosis.
METHODS: Participants included gene negative and gene positive prHD participants who were enrolled in the PREDICT-HD study. The CAG-age product (CAP) score was the measure of an individual's genetic signature. A factor analysis of 18 tests was performed to identify sets of measures or latent factors that elucidated core constructs of tests. Factor scores were then fit to a survival model to evaluate their ability to predict time to diagnosis.
RESULTS: Six factors were identified: (1) speed/inhibition, (2) verbal working memory, (3) motor planning/speed, (4) attention-information integration, (5) sensory-perceptual processing and (6) verbal learning/memory. Factor scores were sensitive to worsening of cognitive functioning in prHD, typically more so than performances on individual tests comprising the factors. Only the motor planning/speed and sensory-perceptual processing factors predicted time to diagnosis, after controlling for CAP scores and motor symptoms. Conclusions The results suggest that motor planning/speed and sensory-perceptual processing are important markers of disease prognosis. The findings also have implications for using composite indices of cognition in preventive Huntington's disease trials where they may be more sensitive than individual tests.

Entities:  

Mesh:

Year:  2012        PMID: 22451099      PMCID: PMC3812822          DOI: 10.1136/jnnp-2011-301732

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN: 0022-3050            Impact factor:   10.154


  34 in total

1.  Impairments in source memory for olfactory and visual stimuli in preclinical and clinical stages of Huntington's disease.

Authors:  Eva Pirogovsky; Paul E Gilbert; Mark Jacobson; Guerry Peavy; Spencer Wetter; Jody Goldstein; Jody Corey-Bloom; Claire Murphy
Journal:  J Clin Exp Neuropsychol       Date:  2007-05       Impact factor: 2.475

2.  Defective emotion recognition in early HD is neuropsychologically and anatomically generic.

Authors:  Susie M D Henley; Edward J Wild; Nicola Z Hobbs; Jason D Warren; Chris Frost; Rachael I Scahill; Gerard R Ridgway; David G MacManus; Roger A Barker; Nick C Fox; Sarah J Tabrizi
Journal:  Neuropsychologia       Date:  2008-03-06       Impact factor: 3.139

3.  Neural modulation of temporal encoding, maintenance, and decision processes.

Authors:  Deborah L Harrington; Janice L Zimbelman; Sean C Hinton; Stephen M Rao
Journal:  Cereb Cortex       Date:  2009-09-24       Impact factor: 5.357

4.  Neurocognitive signs in prodromal Huntington disease.

Authors:  Julie C Stout; Jane S Paulsen; Sarah Queller; Andrea C Solomon; Kathryn B Whitlock; J Colin Campbell; Noelle Carlozzi; Kevin Duff; Leigh J Beglinger; Douglas R Langbehn; Shannon A Johnson; Kevin M Biglan; Elizabeth H Aylward
Journal:  Neuropsychology       Date:  2011-01       Impact factor: 3.295

5.  Mild cognitive impairment in prediagnosed Huntington disease.

Authors:  K Duff; J Paulsen; J Mills; L J Beglinger; D J Moser; M M Smith; D Langbehn; J Stout; S Queller; D L Harrington
Journal:  Neurology       Date:  2010-07-07       Impact factor: 9.910

6.  fMRI biomarker of early neuronal dysfunction in presymptomatic Huntington's Disease.

Authors:  Jane S Paulsen; Janice L Zimbelman; Sean C Hinton; Douglas R Langbehn; Catherine L Leveroni; Michelle L Benjamin; Norman C Reynolds; Stephen M Rao
Journal:  AJNR Am J Neuroradiol       Date:  2004 Nov-Dec       Impact factor: 3.825

7.  Preclinical Huntington's disease: compensatory brain responses during learning.

Authors:  Andrew Feigin; Maria-Felice Ghilardi; Chaorui Huang; Yilong Ma; Maren Carbon; Mark Guttman; Jane S Paulsen; Claude P Ghez; David Eidelberg
Journal:  Ann Neurol       Date:  2006-01       Impact factor: 10.422

8.  A new polymerase chain reaction (PCR) assay for the trinucleotide repeat that is unstable and expanded on Huntington's disease chromosomes.

Authors:  J P Warner; L H Barron; D J Brock
Journal:  Mol Cell Probes       Date:  1993-06       Impact factor: 2.365

9.  Biological and clinical manifestations of Huntington's disease in the longitudinal TRACK-HD study: cross-sectional analysis of baseline data.

Authors:  Sarah J Tabrizi; Douglas R Langbehn; Blair R Leavitt; Raymund Ac Roos; Alexandra Durr; David Craufurd; Christopher Kennard; Stephen L Hicks; Nick C Fox; Rachael I Scahill; Beth Borowsky; Allan J Tobin; H Diana Rosas; Hans Johnson; Ralf Reilmann; Bernhard Landwehrmeyer; Julie C Stout
Journal:  Lancet Neurol       Date:  2009-07-29       Impact factor: 44.182

10.  Predictors of diagnosis in Huntington disease.

Authors:  Douglas R Langbehn; Jane S Paulsen
Journal:  Neurology       Date:  2007-05-15       Impact factor: 9.910

View more
  38 in total

1.  Prediction of manifest Huntington's disease with clinical and imaging measures: a prospective observational study.

Authors:  Jane S Paulsen; Jeffrey D Long; Christopher A Ross; Deborah L Harrington; Cheryl J Erwin; Janet K Williams; Holly James Westervelt; Hans J Johnson; Elizabeth H Aylward; Ying Zhang; H Jeremy Bockholt; Roger A Barker
Journal:  Lancet Neurol       Date:  2014-11-03       Impact factor: 44.182

2.  Regional atrophy associated with cognitive and motor function in prodromal Huntington disease.

Authors:  Elizabeth H Aylward; Deborah L Harrington; James A Mills; Peggy C Nopoulos; Christopher A Ross; Jeffrey D Long; Dawei Liu; Holly K Westervelt; Jane S Paulsen
Journal:  J Huntingtons Dis       Date:  2013

3.  Disruption of response inhibition circuits in prodromal Huntington disease.

Authors:  Julia A Rao; Deborah L Harrington; Sally Durgerian; Christine Reece; Lyla Mourany; Katherine Koenig; Mark J Lowe; Vincent A Magnotta; Jeffrey D Long; Hans J Johnson; Jane S Paulsen; Stephen M Rao
Journal:  Cortex       Date:  2014-06-02       Impact factor: 4.027

4.  Movement sequencing in Huntington disease.

Authors:  Nellie Georgiou-Karistianis; Jeffrey D Long; Spencer G Lourens; Julie C Stout; James A Mills; Jane S Paulsen
Journal:  World J Biol Psychiatry       Date:  2014-03-28       Impact factor: 4.132

5.  Striatal metabolism and psychomotor speed as predictors of motor onset in Huntington's disease.

Authors:  Meike Herben-Dekker; Joost C H van Oostrom; Raymund A C Roos; Caroline K Jurgens; Marie-Noëlle W Witjes-Ané; Hubertus P H Kremer; Klaus L Leenders; Jacoba M Spikman
Journal:  J Neurol       Date:  2014-04-30       Impact factor: 4.849

6.  Onset of Huntington's disease: can it be purely cognitive?

Authors:  Jane S Paulsen; Jeffrey D Long
Journal:  Mov Disord       Date:  2014-08-20       Impact factor: 10.338

7.  Cross-sectional and longitudinal multimodal structural imaging in prodromal Huntington's disease.

Authors:  Deborah L Harrington; Jeffrey D Long; Sally Durgerian; Lyla Mourany; Katherine Koenig; Aaron Bonner-Jackson; Jane S Paulsen; Stephen M Rao
Journal:  Mov Disord       Date:  2016-09-13       Impact factor: 10.338

8.  The impact of oculomotor functioning on neuropsychological performance in Huntington disease.

Authors:  Janessa O Carvalho; Jeffrey D Long; Holly J Westervelt; Megan M Smith; Jared M Bruce; Ji-In Kim; James A Mills; Jane S Paulsen
Journal:  J Clin Exp Neuropsychol       Date:  2016       Impact factor: 2.475

9.  Quantitative 7T phase imaging in premanifest Huntington disease.

Authors:  A C Apple; K L Possin; G Satris; E Johnson; J M Lupo; A Jakary; K Wong; D A C Kelley; G A Kang; S J Sha; J H Kramer; M D Geschwind; S J Nelson; C P Hess
Journal:  AJNR Am J Neuroradiol       Date:  2014-04-17       Impact factor: 3.825

10.  Intra-individual Variability in Prodromal Huntington Disease and Its Relationship to Genetic Burden.

Authors:  Mandi Musso; Holly James Westervelt; Jeffrey D Long; Erin Morgan; Steven Paul Woods; Megan M Smith; Wenjing Lu; Jane S Paulsen
Journal:  J Int Neuropsychol Soc       Date:  2015-01       Impact factor: 2.892

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.